We are live on ! Find out more
PALI icon

Palisade Bio
PALI

5 hedge funds and large institutions have $3.95M invested in Palisade Bio in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

9.44% less ownership

Funds ownership: 23.14% → 13.7% (-9.4%)

17% less funds holding

Funds holding: 6 → 5 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

89% less capital inflows, than outflows

Capital inflows: $314K | Capital outflows: $2.81M

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$314K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$1.26M
2
Putnam Investments
Putnam Investments
Massachusetts
-$1.07M
3
Anson Funds Management
Anson Funds Management
Texas
-$354K
4
Mackenzie Financial
Mackenzie Financial
Ontario, Canada
-$57K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$28K

PALI Hedge Fund Activity: Q3 2016 in Review

5 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q3 2016, worth a combined $3.95M — down 35% from $6.08M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of PALI and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest buyer was Geode Capital Management, opening a new position worth an estimated $314K. The largest seller was Sabby Management, cutting an estimated $1.26M.

  • 5 institutional investors held Palisade Bio (PALI) as of Q3 2016, down from 6 in Q2 2016.
  • Funds reported $3.95M of Palisade Bio stock for Q3 2016, down 35% quarter-over-quarter.
  • 1 fund opened new Palisade Bio positions in Q3 2016 and 2 closed out, a net change of -1 holder.
  • The largest Palisade Bio buyer in Q3 2016 was Geode Capital Management, an estimated $314K added.
  • The largest Palisade Bio seller in Q3 2016 was Sabby Management, an estimated $1.26M sold.

Based on aggregated 13F filings for Q3 2016.